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Research
The effects of endocrine-disrupting   chemicals 
critically depend on the developmental tim-
ing of exposure and the concentration of 
active chemical that actually reaches the tar-
get tissue. Exposure to estrogenic chemicals 
is a well-documented risk to human health 
based on the experience with prenatal expo-
sure to diethylstilbestrol (DES) and its effects 
on development of the female reproductive 
tract (FRT). Many estrogenic compounds 
are found as environmental contaminants 
at levels sufficient to have adverse effects on 
human health. Phytoestrogens in the diet or 
nutritional supplements are common sources 
of environ  mental estrogen exposure (Reinli 
and Block 1996). The most abundant dietary 
phyto  estrogens are the isoflavones genistein 
(Gen) and daidzein, which are present in 
soybean-derived products (Reinli and Block 
1996). Even in strict vegetarians, adult 
serum isoflavone levels are low (≤ 0.5 μM) 
and should have minimal estrogenic activity 
(Jefferson 2010; Peeters et al. 2007).
In contrast to adults, infants fed soy-based 
formula have relatively high serum isofla-
vone concentrations; in a recent study, Cao 
et al. (2009) found that the 25th, 50th, and 
75th percentiles in serum were 1.5, 3.3, and 
5.4 μM, respectively, and the highest con-
centration was 13.2 μM. In animal models 
these levels are clearly estrogenic, as indicated 
by uterine wet weight bio  assays (Jefferson 
and Williams 2010). Two prospective studies 
demon  strate that soy-based infant formula 
elicits estrogenic responses in the developing 
human female (Bernbaum et al. 2008; Zung 
et al. 2008). Limited epidemiological infor-
mation is available regarding long-term effects 
of infant exposure to soy-based formulas, but 
in a recent large study, D’Aloisio et al. (2010) 
reported an increased incidence of physician-
diagnosed fibroids by 35 years of age. These 
studies suggest that neo  natal exposure to 
phyto  estrogens or other environ  mental estro-
genic chemicals could have a long-term effect 
on adult female reproductive health.
FRT development is similar in most 
mammals, although the timing of morpho-
genesis differs among species. In the mouse, 
the FRT develops from the Müllerian duct 
beginning on gestation day (GD) 13 (Masse 
et al. 2009). Prenatal FRT develop  ment is 
controlled by several transcription factors and 
secreted signaling glyco  proteins of the Wnt 
(wingless-related MMTV integration site) 
and hedgehog families. Anterior–posterior 
(AP) patterning of the Müllerian duct is regu-
lated by positional information derived from 
the Hoxa (homeobox A cluster) family of 
homeo  box transcription factors. Expression of 
these genes becomes spatially restricted before 
birth, and distinct FRT regions eventually 
develop that correlate with increased expres-
sion of specific Hoxa genes: Hoxa9 in the ovi-
duct, Hoxa10 and Hoxa11 in the uterus and 
upper cervix, and Hoxa13 in the lower cervix 
and vagina (Block et al. 2000; Ma et al. 1998; 
Taylor et al. 1997). 
Epithelial cell differentiation in the mouse 
FRT begins after birth and continues until 
adulthood. At birth, the oviduct is a simple 
tubular structure with a single layer of colum-
nar epithelium. During the neo  natal period, 
this epithelium differentiates into secretory 
or ciliated columnar cells in response to cues 
received from the under  lying mesenchyme 
that vary along the AP axis (Yamanouchi 
et al. 2010). These differences result in dis-
tinct patterns of epithelial morpho  genesis 
such that the oviduct infundibulum and 
ampulla consist largely of ciliated epithelial 
cells, whereas the isthmus has more secretory 
cells. Similarly, uterine and vaginal mesen-
chymal cells generate cues that determine the 
epithelial cell types in those regions, with the 
adult uterus having mainly simple columnar 
cells and the vagina developing a stratified 
squamous epithelium (Kurita et al. 2001).
The neo  natal FRT is highly sensitive to 
estrogenic disruption during morpho  genesis 
and cellular differentiation. Numerous studies   
performed in animal models show that pre-
natal or neo  natal exposure to estrogenic com-
pounds causes dramatic alterations in FRT 
development and can lead to FRT cancers 
(Ma 2009). To determine whether exposure 
to environmentally relevant phyto  estrogens 
has similar effects on FRT develop  ment and 
function, we used a mouse model of sub-
cutaneous Gen exposure on post  natal days 
(PND) 1–5 (50 mg/kg/day). As long as the 
final serum Gen concentration is similar, the 
effects of Gen derived from oral exposure 
during the neo  natal period are comparable 
Address correspondence to C.J. Williams, NIEHS/
NIH/DHHS, P.O. Box 12233, MD E4-05, Research 
Triangle Park, NC 27709 USA. Telephone: (919) 
541-2158. Fax: (919) 541-0696. E-mail: williamsc5@
niehs.nih.gov
Supplemental Material is available online (http://
dx.doi.org/10.1289/ehp.1104018).
We thank S. Wagner and E. Ney for technical assis-
tance, H. Kinyamu and H. Yao for critical reading of 
the manuscript, and J. Drouin (Institut de recherches 
cliniques de Montréal, Montreal, Quebec, Canada) 
for the Pitx1 antibody. 
This work was supported by the Intramural 
Research Program of the National Institutes of 
Health, National Institute of Environmental Health 
Sciences (Z01-ES102405). 
The authors declare they have no actual or potential 
competing financial interests.
Received 31 May 2011; accepted 2 August 2011.
Permanent Oviduct Posteriorization after Neonatal Exposure to the 
Phytoestrogen Genistein
Wendy N. Jefferson,1 Elizabeth Padilla-Banks,1 Jazma Y. Phelps,1 Kevin E. Gerrish,2 and Carmen J. Williams1
1Reproductive Medicine Group, Laboratory of Reproductive and Developmental Toxicology, and 2Microarray Group, National Institute 
of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Research Triangle Park, 
North Carolina, USA
Ba c k g r o u n d: Preimplantation embryo loss during oviduct transit has been observed in adult mice 
after a 5‑day neonatal exposure to the phytoestrogen genistein (Gen; 50 mg/kg/day).
oB j e c t i v e: We investigated the mechanisms underlying the contribution of the oviduct to infertility. 
Me t h o d s : Female mice were treated on postnatal days 1–5 with corn oil or Gen (50 mg/kg/day). 
We compared morphology, gene expression, and protein expression in different regions of the 
reproductive tracts of Gen‑treated mice with those of control littermates at several time points.
re s u l t s: Neonatal Gen treatment resulted in substantial changes in expression of genes that modu‑
late neonatal oviduct morphogenesis, including Hoxa (homeobox A cluster), Wnt (wingless‑related 
MMTV integration site), and hedgehog signaling genes. An estrogen receptor antagonist blocked 
these effects, indicating that they were induced by the estrogenic activity of Gen. Oviducts of adults 
treated neonatally with Gen had abnormal morphology and were stably “posteriorized,” as indicated 
by altered Hoxa gene patterning during the time of treatment and dramatic, permanent up‑regulation   
of homeobox genes (e.g., Pitx1, Six1) normally expressed only in the cervix and vagina.
co n c l u s i o n s : Neonatal exposure to estrogenic environmental chemicals permanently disrupts 
oviduct morphogenesis and adult gene expression patterns, and these changes likely contribute to 
the infertility phenotype.
key w o r d s : developmental patterning, female reproductive tract, genistein, homeobox gene. 
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to those observed when Gen is adminis  tered 
sub  cutaneously (Jefferson et al. 2009a). This 
model generates serum Gen levels [maxi-
mum concentration (Cmax) in female pups, 
6.8 μM] similar to those found in human 
infants fed soy-based infant formula (Cao 
et al. 2009; Doerge et al. 2002). As adults, 
these mice have multi  oocyte follicles, lack 
regular estrous cycles, and are infertile even 
after super  ovulation, and approximately 30% 
develop uterine cancer (Jefferson et al. 2005; 
Newbold et al. 2001). Abnormalities in both 
the oviduct and uterus contribute to the infer-
tility pheno  type. Although the mice become 
pregnant, approximately 50% of the pre-
implanta  tion embryos die in the oviduct after 
the two-cell stage, and the uterus does not 
support implantation (Jefferson et al. 2009b). 
The goal of the present study was to test the 
hypothesis that neo  natal Gen treatment causes 
permanent changes in oviduct gene expres-
sion and morphology that could explain the 
oviduct’s contribution to infertility.
Materials and Methods
Animals and treatments. All animal procedures 
complied with National Institutes of Health/
National Institute of Environmental Health 
Sciences animal care guidelines; animals were 
treated humanely and with regard for alle-
viation of suffering. Mice were fed NIH-31 
mouse chow (Zeigler Brothers, Gardners, PA), 
which was assayed for phyto  estrogen con-
tent as previously described (Jefferson et al. 
2009b). Female CD-1 pups were injected sub-
cutaneously on PND1–PND5 with corn oil 
(control) or Gen (50 mg/kg/day; Sigma, St. 
Louis, MO), ICI-182780 (ICI; 1 mg/kg/day; 
Sigma), or ICI (1 mg/kg/day) 30 min before 
Gen (50 mg/kg/day). Gen was prepared in 
a suspension of corn oil at 5 mg/mL, and 
ICI was dissolved in corn oil at 1 mg/mL. 
All treatments were delivered in 20 μL corn 
oil, and doses were calculated based on a pup 
weight of 2.0 g. At 6–8 weeks of age, the 
female mice under  went super  ovulation [equine   
chorionic gonadotropin followed by human 
chorionic gonadotropin (hCG), both at 5.0 IU 
in 0.1 mL saline; both from Calbiochem, 
Gibbstown, NJ] or super  ovulation and mating 
as described previously (Jefferson et al. 2009b). 
Only plug-positive mated females were used in 
experiments requiring pregnant mice.
Real-time reverse-transcriptase polymerase 
chain reaction (RT-PCR). Samples were 
collected as follows (n = 3–6 independent 
biological replicates per group). On PND1, 
oviducts, uteri, and cervix/vagina from five 
mice were pooled per biological replicate. 
On PND5, oviducts, uteri, and cervix/vagina 
were collected 4 hr after the last treatment; 
oviducts from three mice were pooled per 
biological replicate, but uterus and cervix/
vagina samples were from individual mice. 
For PND22 pups and adults, both oviducts 
from one mouse were pooled per biological 
replicate. For adult non  pregnant mice, ovi-
ducts of super  ovulated females were collected 
before (8 hr after hCG) and after (15 hr after 
hCG) ovulation, and cumulus masses were 
removed. For adult pregnant mice, oviducts 
of super  ovulated females were collected on 
GD2 or GD4 (48 hr or 96 hr after hCG, 
respectively), and embryos were removed. For 
untreated adult FRT samples, oviducts (pair), 
uterus, cervix, and vagina collected from one 
mouse per biological replicate.
Total RNA was isolated, and cDNA was 
generated from 1 μg RNA using standard pro-
tocols. Primers were designed to amplify exon 
junctions. RT-PCR was performed on 20 ng 
cDNA using SYBR® Green–based detec-
tion on an ABI 7200 HT sequence detec-
tor (Applied Biosystems, Foster City, CA). 
Relative gene expression was calculated by the 
ΔCt method (Pfaffl 2001) using cyclophilin A 
(Ppia) expression for normalization.
Microarray analysis. Oviducts were col-
lected on GD2 (48 hr after hCG), and embryos 
were removed. RNA was isolated using the 
RNeasy Mini Kit (Qiagen, Valencia, CA). 
Gene expression analysis was conducted on 
four independent biological replicates for each 
group using Agilent Whole Mouse Genome 
4 × 44 multi  plex format oligo arrays (Agilent 
Technologies, Santa Clara, CA). Slides were 
scanned with an Agilent Scanner, and data 
were obtained using Agilent Feature Extraction 
software (version 9.5), which performed error 
modeling, adjusting for additive and multipli-
cative noise. The resulting data were processed 
using Rosetta Resolver® (version 7.2; Rosetta 
Biosoftware, Kirkland, WA) and Ingenuity 
Pathway Analysis (Ingenuity Systems, Redwood 
City, CA) and deposited in the National Center 
for Biotechnology Information (NCBI) Gene 
Expression Omnibus (accession no. GSE27639; 
NCBI, Bethesda, MD). 
Histology and immunohisto  chemistry. 
Formalin-fixed tissues were paraffin embed-
ded and sectioned at 5 μm. Sections were 
stained with hematoxylin and eosin (H&E) 
or Masson’s trichrome according to standard 
protocols. For Pitx1 (paired-like homeo-
domain transcription factor 1) immuno-
histo  chemistry, sections were blocked with 
5% bovine serum albumin (BSA) in Tris-
buffered saline/Tween 20 (TBST). Rabbit 
polyclonal anti-Pitx1 antibody (Tremblay 
et al. 1998) was diluted 1:150 in TBST con-
taining 1% BSA and 1% milk. Biotinylated 
anti-rabbit IgG (1:500; Vector Laboratories, 
Burlingame, CA), ExtrAvidin (1:50; Sigma), 
and NovaRED (Vector) were used for detec-
tion. For E-cadherin immuno  histo  chemistry, 
sections were blocked with 10% horse serum 
and avidin/biotin blocking reagent (Vector), 
and E-cadherin antibody (Sigma) was used at 
a 1:150 dilution. The secondary antibody was 
from the Vectastain Elite Kit (Vector), and 
diaminobenzidine was used for visualization. 
Immunoblotting. Total oviduct protein 
(5 μg/mouse in each lane) was separated on 
Novex 4–12% Tris-glycine gels and trans-
ferred to polyvinyl difluoride (Invitrogen, 
Carlsbad, CA). Blots were blocked with 5% 
milk in TBST and then incubated with either 
Six1 [sine oculis-related homeobox 1 homolog 
(Drosophila); 1:1,000; Abcam, Cambridge, 
UK] or β-actin (0.2 μg/mL; Sigma) primary 
anti  bodies followed by horseradish peroxidase– 
conjugated anti-rabbit or anti-mouse IgG 
(Amersham, Piscataway, NJ). Bands were 
visualized using West Femto Reagents (Pierce, 
Rockford, IL).
Statistical analysis. We analyzed data 
using JMP software (version 9; SAS Institute 
Inc., Cary, NC). Student’s t-tests were used 
to compare control and Gen-treated samples 
at each time point.
Results
Abnormal oviduct histology after neo  natal Gen 
treatment. As a first step in determining why 
preimplantation embryos from neo  natal Gen-
treated mice had poor survival in the oviduct 
after the two-cell stage, we analyzed the histol-
ogy of oviducts collected on GD2. Oviducts 
from Gen-treated mice retained the expected 
regional differences between the infundibu-
lum, ampulla, and isthmus (Figure 1A–H); 
however, significant abnormalities were pres-
ent in tissue and cellular morphology com-
pared with controls. The stromal and muscle 
compartments were abnormally thickened 
in all oviduct regions, reminiscent of uter-
ine myometrium and stroma (Figure 1A–H). 
The thickened areas mainly consisted of addi-
tional muscle tissue, and many areas did not 
have the normal clearly defined outer and 
inner smooth muscle layers (Figure 1I,J). 
In some areas of the ampulla, pseudoglands 
were near the outer epithelial surface of the 
oviduct, with no intervening muscle layers 
(Figure 1J). There were localized areas of 
excessive epithelial proliferation, and many 
regions had areas of epithelial disorganiza-
tion that were particularly apparent after cell 
borders were labeled by immuno  staining for 
E-cadherin (Figure 1K,L). This staining also 
revealed that the epithelial cells had enlarged, 
rounded nuclei and were cuboidal rather than 
the predominant tall columnar epithelial cells 
observed in controls.
Alterations in oviduct gene expression dur-
ing neo  natal Gen treatment. We hypothesized 
that the changes in oviduct morphology were 
a result of Gen-induced alterations in expres-
sion of genes that influence post  natal FRT 
morphogenesis. The effect of Gen treatment 
on oviduct expression of secreted signaling 
proteins and transcription factors previously Neonatal genistein and oviduct posteriorization
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documented to affect FRT development was 
examined by real-time PCR at the comple-
tion of Gen treatment on PND5 (Figure 2). 
Wnt genes required for FRT development 
include Wnt4, Wnt5a, and Wnt7a (Masse 
et al. 2009). There was no difference in Wnt4 
expression, whereas Wnt5a was up-regulated 
and Wnt7a was almost completely repressed 
in Gen-treated mice compared with controls. 
Follistatin-like-1 (Fstl1), a diffusible oviduct 
mesenchymal factor, which promotes forma-
tion of ciliated epithelial cells (Yamanouchi 
et al. 2010), was significantly reduced in Gen-
treated mice compared with controls. Secreted 
proteins in the hedgehog signaling pathway 
can regulate post  natal FRT morphogenesis 
and adult FRT function, and Wnt genes can 
be targets of hedgehog signaling (Franco et al. 
2010). Indian hedgehog (Ihh) and hedge-
hog inter  acting protein (Hhip) were highly 
up-regulated, and desert hedgehog (Dhh) 
was up-regulated 2-fold, after Gen treatment 
compared with controls, whereas sonic hedge-
hog (Shh) was not detected (data not shown). 
GLI-Kruppel family member 1 (Gli1), a com-
mon downstream mediator of hedgehog sig-
naling, was also up-regulated, indicating that 
Gen treatment caused activation of hedgehog 
signaling in the neo  natal oviduct.
Transcription factors that regulate pattern-
ing and differentiation of the FRT include fork-
head box a2 (Foxa2) and the posterior Hoxa 
genes (Jeong et al. 2010). Foxa2 expression 
was up-regulated on PND5 by Gen treatment. 
Expression of Hoxa9, Hoxa10, and Hoxa11 
was decreased in oviducts of Gen-treated mice 
compared with controls, whereas Hoxa13 was 
highly up-regulated. This Hoxa gene expres-
sion pattern indicated that the PND5 oviduct 
was posteriorized; that is, the oviduct expressed 
Hoxa genes in a pattern similar to that nor-
mally observed in the posterior cervical and 
vaginal tissues (Ma et al. 1998).
Alterations in oviduct gene expression on 
GD2. We hypothesized that genes important 
for FRT morpho  genesis and perturbed by 
neo  natal Gen treatment would continue to be 
altered in adult oviducts and that additional 
oviduct genes would be mis  expressed around 
the time of pre  implanta  tion embryo loss. 
Rather than choosing candidate genes, we 
performed a microarray-based gene expression 
analysis of oviducts from control and Gen-
treated mice on GD2. We validated selected 
probes that covered a range of intensity val-
ues and fold changes by real  -time RT-PCR 
[see Supplemental Material, Table 1 (http://
dx.doi.org/10.1289/ehp.1104018)]. Principal 
component analysis showed sample separation 
into distinct groups based on treatment; this 
was confirmed using hierarchical cluster analy-
sis (see Supplemental Material, Figure 1).
Of the > 41,000 probes on the array, 1,125 
probes were significantly altered (analysis 
of variance, p < 0.01) in Gen-treated mice 
compared with controls. Duplicate probes 
and probes with average intensity < 100 in 
both treatment groups were removed from 
the analy  sis data set. Within the remain-
ing probes, 335 genes were up- or down-
  regulated ≥ 2-fold; the most highly altered 
genes are shown in Table 1. Significantly 
Figure 1. Oviduct histology on GD2 in controls (A,E,I,C,G,K) and after Gen treatment (B,F,J,D,H,L). 
(A and B) Low-power view of H&E-stained oviducts; arrows highlight muscle/stroma thickness, and 
embryos are indicated (e). (C–H) H&E-stained oviducts showing typical morphology of infundibu-
lum (C and D), ampulla (E and F), and isthmus (G and H). (I and J) Masson’s trichrome stain, with thickened 
muscle (m) and pseudo  gland (arrow) indicated. (K and L) E-Cadherin immuno  histo  chemistry (brown stain), 
with arrows indicating pseudoglands. Bars = 100 μm. 
Control Gen Gen Control
Figure 2. Expression of genes important for FRT development on PND5 after Gen treatment. Data are 
mean ± SE relative oviduct mRNA expression plotted for indicated genes. 
*p < 0.05 compared with control. 
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altered Ingenuity biological function catego-
ries included development, immune response, 
and cell proliferation [see Supplemental 
Material, Table 2 (http://dx.doi.org/10.1289/
ehp.1104018)]. Four of the six secreted sig-
naling proteins (Wnt7a, Ihh, Dhh, and Hhip) 
and one transcription factor (Foxa2) that were 
altered on PND5 after Gen treatment by PCR 
analysis were also significantly altered on GD2 
by micro  array analysis. Taken together, these 
findings indicate that neo  natal Gen treatment 
permanently altered gene expression in the 
adult oviduct.
Three of the most highly up-regulated 
genes on GD2 were the homeobox transcrip-
tion factors Pitx1, Nkx3-1 [NK-3 transcrip-
tion factor, locus 1 (Drosophila)], and Six1. 
These genes all have critical roles in embry-
onic develop  ment but are not reported to be 
expressed in FRT tissues. We hypothe  sized 
that mis  expression of these early develop  ment 
transcription factors contributed to abnor-
mal oviduct morpho  genesis in Gen-treated 
mice. To test this idea and to further ver-
ify the micro  array data, we performed real-
time RT-PCR on independently collected 
biological replicates. Oviducts were collected 
on PND5, on PND22 (prepubertal) from 
super  ovulated adult mice before and after 
ovulation, and on GD2 and GD4. Pitx1 
and Nkx3-1 were highly up-regulated in 
Gen-treated mice compared with controls 
at all time points (Figure 3A,B). Pitx1 pro-
tein was not detected in control oviducts on 
PND5 (Figure 3C,E). However, Gen treat-
ment induced Pitx1 expression in nuclei of 
sporadic oviduct epithelial cells in all areas 
of the PND5 oviduct (Figure 3D,F). As on 
PND5, Pitx1 was not observed in adult con-
trol oviducts (Figure 3G,I), but it was abun-
dantly expressed in focal areas throughout the 
oviduct epithelium of adult Gen-treated mice 
(Figure 3H,J). Like Pitx1, Six1 mRNA was 
highly up-regulated at all time points, and 
Six1 protein was significantly increased in the 
oviducts of Gen-treated mice compared with 
controls (Figure 3K,L).
Broadly posteriorized oviduct gene expres-
sion after neo  natal Gen treatment. Because 
oviduct Hoxa gene expression was posterior-
ized in Gen-treated mice, we tested the idea 
that aberrant expression of Pitx1, Six1, and 
Nkx3-1 was also related to FRT posterioriza-
tion. To do this, we first needed to determine 
the timing of Hoxa gene pattern establishment 
in controls. Hoxa gene patterning in PND1 
controls resembled that in adult controls; that 
is, the highest levels of Hoxa9 were in the 
oviduct, Hoxa10 and Hoxa11 in the uterus, 
and Hoxa13 in the cervix/vagina (Figure 4A). 
These findings, together with alterations in 
the oviduct Hoxa pattern in Gen-treated 
mice on PND5 (Figure 2), indicate that Gen 
exposure disrupted maintenance of previously 
established Hoxa gene patterning.
To determine if genes highly up-regulated 
in the PND5 oviduct by Gen treatment are 
normally expressed in the posterior FRT, we 
compared gene expression levels in the ovi-
duct, uterus, cervix, and vagina of control 
mice. Pitx1, Six1, and Nkx3-1, like Hoxa13, 
were expressed exclusively in the cervix/vagina 
and not in the uterus or oviduct on PND1 
(Figure 4A) and PND5 (data not shown). 
This expression pattern was still observed in 
control adults, when Pitx1, Six1, Nkx3-1, 
and Hoxa13 were highly expressed in the 
vagina and cervix but had minimal expres-
sion in the uterus or oviduct (Figure 4B). 
There was no Pitx1 protein in the adult uterus 
(Figure 4C). However, beginning in the cervix 
at the squamo  columnar junction, Pitx1 was 
detected in the nuclei of squamous epithelial 
cells (Figure 4D), and the staining intensity 
increased in vaginal epithelium (Figure 4E). 
Expression of the secreted signaling factors 
Wnt4, Wnt5a, Wnt7a, and Fstl1 was simi-
lar in all regions of the FRT on PND1 and 
PND5 and in adults (data not shown). In 
contrast, several hedgehog pathway genes and 
Foxa2 were more highly expressed on PND1 
in the cervix/vagina compared with both the 
oviduct (Ihh, 11.0-fold; Dhh, 5.8-fold; Hhip, 
42.1-fold; and Foxa2, 6.1-fold increased) and 
uterus (Ihh, 9.4-fold; Dhh, 6.2-fold; Hhip, 
63.1-fold; and Foxa2, 651.7-fold increased), 
suggesting that these genes are also normally 
restricted to the posterior FRT. Together, 
these data demonstrate that neo  natal Gen 
treatment blocked the normal process of 
transcriptional silencing of many posterior 
develop  mental genes in the anterior FRT.
To determine if the effects of neo  natal 
Gen treatment on the oviduct are medi-
ated by its estrogenic actions (Jefferson et al. 
2002), we examined whether the estrogen 
receptor (ER) antagonist ICI (Wakeling and 
Bowler 1992) blocked these effects. Neo-
natal mice treated with both Gen and ICI 
did not have altered expression of Hoxa9 and 
Hoxa13, nor did they have altered expression 
of the three most highly up-regulated homeo-
box transcription factors (Pitx1, Six1, and 
Nkx3-1) observed in mice treated with Gen 
alone (Figure 5). These findings indicate that 
molecu  lar posteriorization of the oviduct in 
response to Gen treatment is mediated by its 
estrogenic action.
Discussion
The results presented here demonstrate that a 
brief neo  natal exposure to the phyto  estrogen 
Gen causes substantial permanent changes 
in oviduct morphology and gene expression 
in mice. The altered expression of Hoxa and 
Wnt genes in the oviduct combined with 
aberrant expression of homeobox transcrip-
tion factors that are normally expressed only 
in the posterior FRT likely account for abnor-
mal oviduct differentiation and subsequent 
abnormal tissue architecture and function 
later in life.
Cellular differentiation of the FRT occurs 
during post  natal development in rodents, 
ruminants, non  human primates, and humans 
(Gray et al. 2001). Based on the presence of 
Table 1. Most highly up- and down-regulated oviduct genes.
Gene Gene name Fold change (gene/control)
Up-regulated genes
Pitx1 paired-like homeodomain transcription factor 1 99.3
Serpina3a serine (or cysteine) peptidase inhibitor, clade A, member 3A 10.3
Hao3 hydroxyacid oxidase (glycolate oxidase) 3 8.4
Lipf lipase, gastric 7.6
Osap ovary-specific acidic protein 7.5
Igkv5-43 immunoglobulin kappa chain variable 5-43 7.4
Prss35 protease, serine, 35 7.1
Cxcl15 chemokine (C-X-C motif) ligand 15 6.9
Six1 sine oculis-related homeobox 1 homolog (Drosophila) 6.8
Serpina5 serine (or cysteine) peptidase inhibitor, clade A, member 5 6.8
Cyp11a1 cytochrome P450, family 11, subfamily a, polypeptide 1 6.7
Nkx3-1  NK-3 transcription factor, locus 1 (Drosophila) 5.9
Down-regulated genes
Kcne1 potassium voltage-gated channel, Isk-related subfamily, member 1 –4.9
Serpina11 serine (or cysteine) peptidase inhibitor, clade A, member 11 –4.9
Myh7 myosin, heavy polypeptide 7, cardiac muscle, beta –5.1
Myh6 myosin, heavy polypeptide 6, cardiac muscle, alpha –5.2
Coch Cochlin, coagulation factor C homolog coagulation factor C 
homolog (Limulus polyphemus) 
–5.3
Serpina1d serine (or cysteine) peptidase inhibitor, clade A, member 1D –5.7
Olah oleoyl-ACP hydrolase –5.9
Spock1 sparc/osteonectin, cwcv and kazal-like domains proteoglycan 1 –6.0
Serpina1e serine (or cysteine) peptidase inhibitor, clade A, member 1E –6.2
Serpina1b serine (or cysteine) preptidase inhibitor, clade A, member 1B –6.2
Epha6 Eph receptor A6  –7.8
Ano2 anoctamin 2 –18.4Neonatal genistein and oviduct posteriorization
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ERα in the FRT epithelium at birth, it is 
not surprising that an estrogenic compound 
adminis  tered during this period disrupts FRT 
morpho  genesis and cellular differentiation. 
Indeed, numerous reports have described the 
effects of the potent synthetic estrogen DES 
on both pre  natal and post  natal FRT develop-
ment. Most of these studies have focused on 
the uterus; however, a few reports described 
the effects of DES on oviduct histo  pathology 
(Newbold et al. 1985). Furthermore, the doses 
of DES used had much higher estrogenic 
activity than that of estrogenic chemicals typi-
cally encountered in daily life. The neo  natal 
Gen dosing strategy used in the present study 
results in a serum Gen concentration similar 
to that in human infants fed soy-based infant 
formula (Jefferson and Williams 2010). This 
model is also likely relevant to human expo-
sure to low levels of other estrogenic environ-
mental chemicals.
Prenatal DES treatment alters the expres-
sion pattern of Wnt genes in the FRT on 
GD19 (Suzuki et al. 2007). Similarly, in 
the present study, neo  natal Gen treatment 
resulted in increased Wnt5a expression and 
significantly reduced Wnt7a expression in 
the oviduct on PND5, indicating that both 
pre  natal and neo  natal exposure to estrogenic 
compounds disrupts Wnt gene expression 
in the FRT. Stratified luminal epithelium is 
observed in the uterus of Wnt7a-null mice 
(Miller and Sassoon 1998), and in the pres-
ent neo  natal Gen model we found Wnt7a 
repression and a marked up-regulation in the 
oviduct of genes that are normally observed 
in stratified cervical/vaginal squamous epi-
thelium. These findings support the idea 
that Wnt7a is required for maintenance of 
the columnar epithelium in the oviduct and 
uterus and that Gen-induced Wnt7a repres-
sion in the neo  natal FRT may promote ovi-
duct posteriorization. However, if reduction in 
Wnt7a were sufficient to promote a cervical/ 
vaginal pheno  type, we would expect that in 
control mice, Wnt7a expression would be 
lower in these tissues than in the uterus and 
oviduct. Instead, in controls during the neo-
natal period, Wnt7a is highly expressed in 
the cervix and vagina and is not differentially 
expressed compared with the uterus and ovi-
duct. For this reason, the oviduct posterioriza-
tion in Gen-treated mice cannot be attributed 
to reduction in Wnt7a alone.
Hoxa genes direct AP patterning of the 
FRT and maintain a distinct spatial distribu-
tion in adults. From GD16.5 through GD19, 
Hoxa9 is similarly expressed throughout the 
FRT, but Hoxa10, Hoxa11, and Hoxa13 are 
differentially expressed along the AP axis, 
with Hoxa10 and Hoxa11 highest in the 
uterus and Hoxa13 highest in the cervix and 
vagina (Ma et al. 1998; Suzuki et al. 2007). 
On the day of birth (PND1), we found that 
Hoxa10, Hoxa11, and Hoxa13 had an expres-
sion pattern similar to that on E19, whereas 
Hoxa9 was more highly expressed in the ovi-
duct compared with the uterus and cervix/
vagina. This Hoxa gene expression pattern 
is permanently maintained from the day of 
birth (PND1) forward because FRT tissues 
from PND14 and adult mice have a simi-
lar expression pattern (Taylor et al. 1997). 
Hoxa9 is not essential for FRT development 
because Hoxa9-null mice have normal fertility 
(Fromental-Ramain et al. 1996). In contrast, 
Hoxa10- and Hoxa11-null mice have abnor-
mal FRT development and function (Benson 
et al. 1996; Gendron et al. 1997). Hoxa13-
null mice have agenesis of the caudal portion 
of the Müllerian duct, and Hoxd13 (homeo-
box D13)-null mice that also lack one copy of 
Figure 3. Expression of Pitx1, Nkx3-1, and Six1 in oviduct after neonatal Gen treatment. (A and B) Relative 
expression (mean ± SE) of Pitx1 (A) and Nkx3-1 (B). (C–J) Pitx1 immuno  histochemistry in PND5   
isthmus (C and D) and ampulla/infundibulum (E and F) and GD2 isthmus (G and H) and ampulla (I and J). 
Bars = 100 μm. (K) Relative expression (mean ± SE) of Six1. (L) Immunoblot of Six1 in oviduct on GD2 (pro-
tein from one mouse per lane). The 8-hr time point was before ovulation; 15 hr was after ovulation, 48 hr 
was GD2; and 96 hr was GD4. 
*p < 0.05 compared with control. 
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Hoxa13 exhibit severe malformations of the 
vagina and external genitalia, suggesting criti-
cal roles for these Hox gene paralogs in pos-
terior FRT development (Fromental-Ramain 
et al. 1996; Warot et al. 1997).
Neonatal Gen exposure alters Hoxa gene 
expression in the oviduct, with Hoxa9, Hoxa10, 
and Hoxa11 expression significantly reduced 
compared with controls and Hoxa13 increased. 
Similarly, Hoxa10 and Hoxa11 are reduced 
in the uterus after neo  natal DES exposure 
(Block et al. 2000; Ma et al. 1998; Suzuki et al. 
2007). Because the adult pattern of Hoxa gene 
expression is normally present at birth, these 
data suggest that Hoxa gene patterning is not 
irreversible once established but retains some 
plasticity in the neo  natal period. This finding is 
consistent with the observation that in Wnt7a-
null mice, Hoxa10 and Hoxa11 expression in 
the uterus is normal at birth but then gradually 
decreases (Miller and Sassoon 1998), suggest-
ing that Wnt7a is required for maintenance of 
FRT Hoxa gene patterning.
Hoxa13 up-regulation may contribute to 
neo  natal Gen-induced posteriorization of the 
oviduct by inducing expression of several genes 
normally restricted to the cervix and vagina. 
This finding is in agreement with a mouse 
knock-in study in which replacement of the 
Hoxa11 homeo  domain with the Hoxa13 
homeo  domain (A1113hd/13hd) resulted in pos-
teriorization of the uterus to resemble a cervix/
vagina–like structure (Zhao and Potter 2001). 
More than 30 genes normally expressed in the 
cervix and not in the uterus were expressed in 
the uterus of the A1113hd/13hd mutants. One 
of these genes was the transcription factor 
Six1, suggesting that Six1 is normally regu-
lated by Hoxa13 via a mechanism involving 
the homeo  domain. In the present study, Six1 
was highly up-regulated in the adult oviduct 
after neo  natal Gen treatment, and we demon-
strated that its up-regulation begins during 
the time of Gen treatment and remains stable 
through adulthood. This expression pattern 
correlates with the up-regu  lation of Hoxa13 
in the oviduct, suggesting that Hoxa13 expres-
sion in the anterior FRT is a proximal factor 
in altering cellular differentiation and causing 
pheno  typic and molecu  lar posteriorization of 
the oviduct.
One explanation for the altered expression 
of Hoxa genes in the oviduct is that Gen-
induced activation of ER-mediated transcrip-
tion disrupts global regulation of Hoxa genes 
in the FRT. Indeed, Hoxa10 and Hoxa11 
are regulated by estrogen in the adult FRT 
(Taylor et al. 1998). Regulation of Hox gene 
expression during mammalian develop  ment 
is complex and involves regulatory RNAs and 
proteins whose activities orchestrate the estab-
lishment and subsequent maintenance of the 
AP Hox expression patterns (for review, see 
Chopra 2010). Because Hoxa patterning in 
Figure 4. Expression of homeobox transcription factors in FRT tissues of control mice. (A and B) Relative 
expression (mean ± SE) of genes in tissues from PND1 (A) and adult (B) mice. (C–E) Pitx1 immuno-
histochemistry in adult uterus (C), cervix (D), and vagina (E). Bar = 50 μm. The arrow in D indicates 
squamo  columnar junction. Abbreviations: cx, cervix; ov, oviduct; ut, uterus; v, vagina. 
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Figure 5. Inhibition of posteriorized gene expression (mean ± SE) by ER antagonist in the oviduct on PND5. 
*p < 0.05 compared with control or Gen + ICI. 
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the FRT is already established at birth, altera-
tions in initiation factors cannot explain Gen-
induced disruption. Instead, alterations in 
maintenance factors, such as polycomb and 
tri  thorax group proteins, that preserve the 
initial Hox gene expression pattern and help 
cells “remember” which regulatory domains 
to keep silent and which ones to keep active, 
are more likely candidates.
Although Hox genes may function 
upstream of Pitx1, Six1, and Nkx3-1 after 
Gen treatment, the converse may also be true. 
These three genes have critical roles in direct-
ing embryonic develop  ment of tissues out-
side the FRT. Six1 regulates develop  ment of 
numerous tissues, including the eye, skeletal 
muscle, and posterior limbs (Christensen et al. 
2008; Laclef et al. 2003). Nkx3-1 is impor-
tant for prostate develop  ment and marks a 
stem cell population that functions during 
prostate regeneration (Sciavolino et al. 1997; 
Wang et al. 2009). Nkx3-1 was previously 
reported to be absent in the FRT, but tis-
sues from the cervix or vagina were not exam-
ined (Sciavolino et al. 1997). Pitx1 is involved 
in develop  ment of anterior branchial arch 
structures and the hindlimb (Lamonerie et al. 
1996; Lanctot et al. 1999; Szeto et al. 1999). 
Pitx1 acts upstream of Hox genes during 
hindlimb specification because mis  expression 
of Pitx1 in the chick wing bud leads to 
increased expression of Hoxc10 and Hoxc11 
and results in transformation into a more leg-
like structure (Logan and Tabin 1999). The 
permanent up-regulation of Pitx1, Six1, and 
Nkx3-1 in the oviduct of Gen-treated mice, 
combined with the importance of these genes 
in development of many embryonic tissues, 
suggests that one or all of these homeobox 
transcription factors may contribute to ovi-
duct posteriorization after Gen treatment. 
Because Six1 causes initiation and metastasis 
of several types of human cancer (Christensen 
et al. 2008), its permanent up-regulation 
could contribute to the observed increase in 
FRT cancers in neo  natal Gen-treated mice 
(Newbold et al. 2001).
Infants fed soy-based formulas have high 
circulating levels of Gen (1.5–13.2 μM) (Cao 
et al. 2009). The subcutaneous injection 
model of Gen exposure used in the present 
study produces serum circulating levels similar 
to those of human infants (Cmax = 6.8 μM in 
female pups). Because the primary exposure 
of humans is oral exposure to the gly  cos  ylated 
form, genistin, we previously compared a dose 
response of oral exposure to genistin with that 
of subcutaneous exposure to Gen in neo  natal 
mice (Jefferson et al. 2009a). Oral exposure to 
genistin in neo  natal mice on PND1–PND5 
produces similar circulating levels of Gen as 
a subcutaneous injection (~ 80%) and similar 
effects on the developing reproductive tract, 
including multi  oocyte follicles in the ovary, 
abnormal estrous cycles, and reduced fertility. 
All of these Gen effects are correlated with the 
circulating level of Gen and the estrogenic 
activity (uterine wet weight increase) during 
the time of treatment and are not dependent 
on the route of adminis  tration or form of Gen 
given. Therefore, the subcutaneous model 
used in the present study is a valid model for 
human infant exposures to Gen.
Conclusions
The findings reported here raise the possibil-
ity that exposure to low levels of estrogenic 
environ  mental chemicals or phyto  estrogens 
during sensitive develop  mental windows can 
alter develop  mental programming of FRT 
tissues. These changes could contribute to 
improper function of the FRT later in life that 
manifests as an infertility pheno  type. Should 
this phenomenon occur in humans, it would 
provide the mechanistic basis for some cases 
of unexplained infertility, which is the sole 
infertility diagnosis in a signifi  cant percentage 
of couples who undergo assisted reproduction 
treatment by in vitro fertilization. In addition, 
the permanent up-regu  lation of develop  mental 
transcription factors in the FRT could have 
long-term effects on its structure and func-
tion, including influencing the develop  ment 
of benign or malignant pathologies.
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